Vetter Pharma
Vetter Pharma, officially known as Vetter Pharma-Fertigung GmbH & Co. KG, is a leading global provider of aseptic filling and packaging services for the pharmaceutical and biotechnology industries. Headquartered in Ravensburg, Germany, the company operates extensively across Europe, North America, and Asia, catering to a diverse clientele. Founded in 1950, Vetter Pharma has achieved significant milestones, including the development of innovative delivery systems and a commitment to high-quality standards. The company specialises in prefilled syringes, vials, and cartridges, distinguished by their precision and reliability. Vetter's strong market position is underscored by its reputation for excellence and a robust portfolio of services that support drug development and commercialisation. With a focus on customer-centric solutions, Vetter Pharma continues to be a trusted partner in the evolving landscape of healthcare.
DitchCarbon Score
How does Vetter Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vetter Pharma's score of 31 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vetter Pharma's reported carbon emissions
In 2023, Vetter Pharma reported total carbon emissions of approximately 21,000,000 kg CO2e, with 17,852,000 kg CO2e attributed to Scope 1 emissions, primarily from stationary combustion. Scope 3 emissions accounted for about 3,613,000 kg CO2e, including significant contributions from business travel and waste generated in operations. In 2022, the company recorded total emissions of about 29,000,000 kg CO2e, with Scope 1 emissions at 18,000,000 kg CO2e and Scope 3 emissions reaching approximately 12,586,000 kg CO2e. The 2021 data indicated total emissions of around 17,770,000 kg CO2e, with Scope 1 emissions at 19,683,000 kg CO2e. Vetter Pharma has committed to near-term climate targets, although it has not set a net-zero target. The company is actively working on reducing its carbon footprint within the pharmaceutical sector, focusing on improving operational efficiencies and reducing emissions from business travel and waste management.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 19,683,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - |
| Scope 3 | - | 00,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Vetter Pharma is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
